Supernus Pharmaceuticals Future Growth
Future criteria checks 4/6
Supernus Pharmaceuticals is forecast to grow earnings and revenue by 58.3% and 6.6% per annum respectively while EPS is expected to grow by 54.6% per annum.
Key information
58.3%
Earnings growth rate
54.6%
EPS growth rate
Pharmaceuticals earnings growth | 20.6% |
Revenue growth rate | 6.6% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 24 Apr 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 693 | 59 | 162 | N/A | 4 |
12/31/2025 | 615 | -25 | 111 | 222 | 4 |
12/31/2024 | 601 | 7 | 88 | 176 | 4 |
12/31/2023 | 608 | 1 | 111 | 111 | N/A |
9/30/2023 | 611 | 26 | 93 | 94 | N/A |
6/30/2023 | 634 | 43 | 71 | 72 | N/A |
3/31/2023 | 668 | 52 | 162 | 162 | N/A |
12/31/2022 | 667 | 61 | 116 | 117 | N/A |
9/30/2022 | 659 | 38 | 138 | 138 | N/A |
6/30/2022 | 630 | 57 | 120 | 120 | N/A |
3/31/2022 | 601 | 73 | 94 | 95 | N/A |
12/31/2021 | 580 | 53 | 125 | 127 | N/A |
9/30/2021 | 564 | 82 | 108 | 110 | N/A |
6/30/2021 | 571 | 100 | 117 | 120 | N/A |
3/31/2021 | 556 | 111 | 163 | 166 | N/A |
12/31/2020 | 520 | 127 | 135 | 138 | N/A |
9/30/2020 | 477 | 129 | 145 | 150 | N/A |
6/30/2020 | 424 | 118 | 177 | 182 | N/A |
3/31/2020 | 402 | 116 | 114 | 119 | N/A |
12/31/2019 | 393 | 113 | 142 | 143 | N/A |
9/30/2019 | 408 | 106 | 131 | 132 | N/A |
6/30/2019 | 409 | 105 | 156 | 157 | N/A |
3/31/2019 | 404 | 103 | 134 | 135 | N/A |
12/31/2018 | 409 | 111 | 128 | 129 | N/A |
9/30/2018 | 381 | 99 | 131 | 132 | N/A |
6/30/2018 | 359 | 87 | 107 | 109 | N/A |
3/31/2018 | 335 | 73 | 126 | 128 | N/A |
12/31/2017 | 302 | 57 | 113 | 115 | N/A |
9/30/2017 | 276 | 58 | N/A | 103 | N/A |
6/30/2017 | 253 | 104 | N/A | 92 | N/A |
3/31/2017 | 228 | 97 | N/A | 83 | N/A |
12/31/2016 | 215 | 91 | N/A | 67 | N/A |
9/30/2016 | 196 | 84 | N/A | 64 | N/A |
6/30/2016 | 179 | 26 | N/A | 35 | N/A |
3/31/2016 | 163 | 18 | N/A | 32 | N/A |
12/31/2015 | 147 | 14 | N/A | 35 | N/A |
9/30/2015 | 135 | 11 | N/A | 18 | N/A |
6/30/2015 | 118 | 5 | N/A | 14 | N/A |
3/31/2015 | 112 | 5 | N/A | -6 | N/A |
12/31/2014 | 93 | -11 | N/A | -24 | N/A |
9/30/2014 | 72 | -37 | N/A | -40 | N/A |
6/30/2014 | 50 | -59 | N/A | -51 | N/A |
3/31/2014 | 21 | -89 | N/A | -60 | N/A |
12/31/2013 | 12 | -92 | N/A | -58 | N/A |
9/30/2013 | 3 | -83 | N/A | -65 | N/A |
6/30/2013 | 2 | -73 | N/A | -60 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: S49's forecast earnings growth (58.3% per year) is above the savings rate (0.6%).
Earnings vs Market: S49's earnings (58.3% per year) are forecast to grow faster than the German market (14.9% per year).
High Growth Earnings: S49's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: S49's revenue (6.6% per year) is forecast to grow faster than the German market (5.4% per year).
High Growth Revenue: S49's revenue (6.6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if S49's Return on Equity is forecast to be high in 3 years time